Study: Potential New Treatment Identified for Liver Disease
Researchers with UC San Diego School of Medicine identified a potential new drug that improved liver fibrosis in patients with NASH by 27%.
UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.